Article Details

Bronchiolitis Obliterans Syndrome Pipeline Drugs Analysis Report, 2023 - Digital Journal

Retrieved on: 2023-11-22 17:21:44

Tags for this article:

Click the tags to see associated articles and topics

Bronchiolitis Obliterans Syndrome Pipeline Drugs Analysis Report, 2023 - Digital Journal. View article details on hiswai:

Excerpt

ALTA 2530: Altavant Sciences; Alvelestat: Mereo BioPharma; Ruxolitinib: Incyte Corporation; Liposomal Cyclosporine A: Zambon Company. Bronchiolitis ...

Article found on: www.digitaljournal.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo